Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-05-30

Aspiration to architecture: multi-omics, AI, digital twins, and blockchain for P4 medicine.

Alex E Mohr, Anil Bajnath, Gail King, Thomas E Ichim, Paniz Jasbi

Systems Precision Engineering and Advanced Research (SPEAR), Theriome Inc, Phoenix, AZ, USA. · pubmed

Abstract

Two decades after its formalization, P4 medicine (predictive, preventive, personalized, participatory) remains more framework than practice. Most implementations stall at single-omics prediction and fail to close the loop across all four dimensions. In this Perspective, we argue that the P4 framework becomes actionable only when each pillar is anchored to a specific, implementable digital technology: multi-omics for prediction, artificial intelligence for prevention, digital twinning for personalization, and blockchain for participation. We propose a tiered multi-omics classification (Tier 1: genomics, measured once; Tier 2: epigenomics/proteomics, periodic; Tier 3: metabolomics/wearables, frequent) and present preliminary metabolomic aging data from 2,072 individuals identifying nine metabolites with linear age associations. We offer a computational definition of personalization requiring baseline state estimation, trajectory prediction, and counterfactual intervention simulation via stochastic digital twin engines. For the participatory pillar, we describe a blockchain architecture enabling patient-controlled data sovereignty and a health data marketplace. These four technologies form a reinforcing flywheel, where longitudinal patient participation enriches upstream data layers. We discuss validation challenges, regulatory gaps, equity concerns, and privacy risks that must be addressed before clinical deployment.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper proposes a framework integrating multi-omics, AI, digital twins, and blockchain to enhance the implementation of P4 medicine for aging-related health management. This research is relevant as it addresses the integration of technologies aimed at improving predictive and preventive strategies in the context of aging and longevity.

Author of this paper? Send a correction.